How much profit has Opthea made this year?
Opthea has made -220.24 M USD this year.
Opthea Net Income 2024
Opthea Net Income
-220.24 M USD
Ticker
OPT.AX
ISIN
AU000000OPT2
WKN
A2AB8J
In 2024, Opthea's profit amounted to -220.24 M USD, a 54.53% increase from the -142.52 M USD profit recorded in the previous year.
The Opthea Net Income history
| YEAR | NET INCOME (undefined USD) |
|---|---|
| 2030e | 727.76 |
| 2029e | 433.2 |
| 2028e | 199.81 |
| 2027e | 97.4 |
| 2026e | -92.36 |
| 2025e | -224.88 |
| 2024 | -220.24 |
| 2023 | -142.52 |
| 2022 | -92.82 |
| 2021 | -45.34 |
| 2020 | -11.12 |
| 2019 | -14.23 |
| 2018 | -11.5 |
| 2017 | -4.21 |
| 2016 | -4.51 |
| 2015 | -5.31 |
| 2014 | -4 |
| 2013 | -4.75 |
| 2012 | -4.84 |
| 2011 | -10.27 |
| 2010 | -6.95 |
| 2009 | -9.92 |
| 2008 | -1.15 |
| 2007 | 11.2 |
| 2006 | -6.47 |
| 2005 | 21.77 |
Opthea Revenue, EBIT, Net Income AU000000OPT2 · A2AB8J
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Opthea, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Opthea from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Opthea’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Opthea. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Opthea’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Opthea’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Opthea’s growth potential.
Opthea Revenue, EBIT and net profit per share
| Date | Opthea Revenue | Opthea EBIT | Opthea Net Income |
|---|---|---|---|
| 2030e | 840 M undefined | 0 undefined | 727.76 M undefined |
| 2029e | 607.67 M undefined | 303.51 M undefined | 433.2 M undefined |
| 2028e | 426.71 M undefined | 130.79 M undefined | 199.81 M undefined |
| 2027e | 382.73 M undefined | 174.21 M undefined | 97.4 M undefined |
| 2026e | 83.01 M undefined | -94.37 M undefined | -92.36 M undefined |
| 2025e | 176,750 undefined | -168.16 M undefined | -224.88 M undefined |
| 2024 | 124,670 undefined | -191.98 M undefined | -220.24 M undefined |
| 2023 | 108,410 undefined | -150.3 M undefined | -142.52 M undefined |
| 2022 | 90,680 undefined | -96.65 M undefined | -92.82 M undefined |
| 2021 | 68,610 undefined | -39.67 M undefined | -45.34 M undefined |
| 2020 | 59,060 undefined | -17.09 M undefined | -11.12 M undefined |
| 2019 | 108,208 undefined | -25 M undefined | -14.23 M undefined |
| 2018 | 778,141 undefined | -19.57 M undefined | -11.5 M undefined |
| 2017 | 390,098 undefined | -6.34 M undefined | -4.21 M undefined |
| 2016 | 530,028 undefined | -5.07 M undefined | -4.51 M undefined |
| 2015 | 939,010 undefined | -8.45 M undefined | -5.31 M undefined |
| 2014 | 880,000 undefined | -6.72 M undefined | -4 M undefined |
| 2013 | 1.15 M undefined | -7 M undefined | -4.75 M undefined |
| 2012 | 1.49 M undefined | -7.72 M undefined | -4.84 M undefined |
| 2011 | 1.83 M undefined | -10.09 M undefined | -10.27 M undefined |
| 2010 | 2.27 M undefined | -8.57 M undefined | -6.95 M undefined |
| 2009 | 3.09 M undefined | -8.12 M undefined | -9.92 M undefined |
| 2008 | 8.15 M undefined | -850,000 undefined | -1.15 M undefined |
| 2007 | 29.89 M undefined | 12.8 M undefined | 11.2 M undefined |
| 2006 | 1.17 M undefined | -3.61 M undefined | -6.47 M undefined |
| 2005 | 47.4 M undefined | 44.38 M undefined | 21.77 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2005 | 47.4 M USD | 44.38 M USD | 21.77 M USD |
| 2006 | 1.17 M USD | -3.61 M USD | -6.47 M USD |
| 2007 | 29.89 M USD | 12.8 M USD | 11.2 M USD |
| 2008 | 8.15 M USD | -850,000 USD | -1.15 M USD |
| 2009 | 3.09 M USD | -8.12 M USD | -9.92 M USD |
| 2010 | 2.27 M USD | -8.57 M USD | -6.95 M USD |
| 2011 | 1.83 M USD | -10.09 M USD | -10.27 M USD |
| 2012 | 1.49 M USD | -7.72 M USD | -4.84 M USD |
| 2013 | 1.15 M USD | -7 M USD | -4.75 M USD |
| 2014 | 880,000 USD | -6.72 M USD | -4 M USD |
| 2015 | 939,010 USD | -8.45 M USD | -5.31 M USD |
| 2016 | 530,028 USD | -5.07 M USD | -4.51 M USD |
| 2017 | 390,098 USD | -6.34 M USD | -4.21 M USD |
| 2018 | 778,141 USD | -19.57 M USD | -11.5 M USD |
| 2019 | 108,208 USD | -25 M USD | -14.23 M USD |
| 2020 | 59,060 USD | -17.09 M USD | -11.12 M USD |
| 2021 | 68,610 USD | -39.67 M USD | -45.34 M USD |
| 2022 | 90,680 USD | -96.65 M USD | -92.82 M USD |
| 2023 | 108,410 USD | -150.3 M USD | -142.52 M USD |
| 2024 | 124,670 USD | -191.98 M USD | -220.24 M USD |
| 2025e | 176,750 USD | -168.16 M USD | -224.88 M USD |
| 2026e | 83.01 M USD | -94.37 M USD | -92.36 M USD |
| 2027e | 382.73 M USD | 174.21 M USD | 97.4 M USD |
| 2028e | 426.71 M USD | 130.79 M USD | 199.81 M USD |
| 2029e | 607.67 M USD | 303.51 M USD | 433.2 M USD |
| 2030e | 840 M USD | 0 USD | 727.76 M USD |
Opthea stock margins AU000000OPT2 · A2AB8J
The Opthea margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Opthea. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Opthea.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Opthea's sales revenue. A higher gross margin percentage indicates that the Opthea retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Opthea's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Opthea's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Opthea's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Opthea. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Opthea's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Opthea Margin History
| Opthea Gross margin | Opthea Profit margin | Opthea EBIT margin | Opthea Profit margin |
|---|---|---|---|
| 2030e | -53.89 % | 0 % | 86.64 % |
| 2029e | -53.89 % | 49.95 % | 71.29 % |
| 2028e | -53.89 % | 30.65 % | 46.83 % |
| 2027e | -53.89 % | 45.52 % | 25.45 % |
| 2026e | -53.89 % | -113.69 % | -111.26 % |
| 2025e | -53.89 % | -95,139.14 % | -127,231.38 % |
| 2024 | -53.89 % | -153,990.47 % | -176,660.07 % |
| 2023 | -53.89 % | -138,642.8 % | -131,464.89 % |
| 2022 | -77 % | -106,579.5 % | -102,357.04 % |
| 2021 | -525.13 % | -57,817.96 % | -66,090.22 % |
| 2020 | -504.44 % | -28,931.29 % | -18,833.73 % |
| 2019 | -72.22 % | -23,102.35 % | -13,146.08 % |
| 2018 | 77.42 % | -2,514.84 % | -1,477.7 % |
| 2017 | 55.1 % | -1,626.42 % | -1,079.99 % |
| 2016 | 54.47 % | -956.48 % | -850.34 % |
| 2015 | 63.29 % | -899.4 % | -565.71 % |
| 2014 | 35.23 % | -763.64 % | -454.55 % |
| 2013 | 46.96 % | -608.7 % | -413.04 % |
| 2012 | -3.36 % | -518.12 % | -324.83 % |
| 2011 | 61.2 % | -551.37 % | -561.2 % |
| 2010 | 48.9 % | -377.53 % | -306.17 % |
| 2009 | 34.3 % | -262.78 % | -321.04 % |
| 2008 | 76.07 % | -10.43 % | -14.11 % |
| 2007 | 66.81 % | 42.82 % | 37.47 % |
| 2006 | 64.96 % | -308.55 % | -552.99 % |
| 2005 | 99.68 % | 93.63 % | 45.93 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2005 | 99.68 % | 93.63 % | 45.93 % |
| 2006 | 64.96 % | -308.55 % | -552.99 % |
| 2007 | 66.81 % | 42.82 % | 37.47 % |
| 2008 | 76.07 % | -10.43 % | -14.11 % |
| 2009 | 34.3 % | -262.78 % | -321.04 % |
| 2010 | 48.9 % | -377.53 % | -306.17 % |
| 2011 | 61.2 % | -551.37 % | -561.2 % |
| 2012 | -3.36 % | -518.12 % | -324.83 % |
| 2013 | 46.96 % | -608.7 % | -413.04 % |
| 2014 | 35.23 % | -763.64 % | -454.55 % |
| 2015 | 63.29 % | -899.4 % | -565.71 % |
| 2016 | 54.47 % | -956.48 % | -850.34 % |
| 2017 | 55.1 % | -1,626.42 % | -1,079.99 % |
| 2018 | 77.42 % | -2,514.84 % | -1,477.7 % |
| 2019 | -72.22 % | -23,102.35 % | -13,146.08 % |
| 2020 | -504.44 % | -28,931.29 % | -18,833.73 % |
| 2021 | -525.13 % | -57,817.96 % | -66,090.22 % |
| 2022 | -77 % | -106,579.5 % | -102,357.04 % |
| 2023 | -53.89 % | -138,642.8 % | -131,464.89 % |
| 2024 | -53.89 % | -153,990.47 % | -176,660.07 % |
| 2025e | -53.89 % | -95,139.14 % | -127,231.38 % |
| 2026e | -53.89 % | -113.69 % | -111.26 % |
| 2027e | -53.89 % | 45.52 % | 25.45 % |
| 2028e | -53.89 % | 30.65 % | 46.83 % |
| 2029e | -53.89 % | 49.95 % | 71.29 % |
| 2030e | -53.89 % | 0 % | 86.64 % |
Opthea Aktienanalyse
What does Opthea do?
Opthea Ltd is a biopharmaceutical company specializing in the development of novel therapies for various eye diseases. The company was founded in 1985 in Melbourne, Australia as a spin-off from the Burnet Institute for Medical Research and Public Health. Since then, Opthea has become a leading company in ophthalmology and is researching innovative therapies that have the potential to improve the lives of millions of patients worldwide. Opthea's business model is to develop novel therapies for various eye diseases and market these therapies through partnerships with established pharmaceutical companies. The company focuses on developing therapies based on the inhibition of growth factors and other signaling pathways that promote the development of abnormal blood vessels and inflammation. This therapeutic principle offers a promising way to effectively treat various eye diseases. Opthea specializes in developing therapies for the treatment of wet age-related macular degeneration (AMD), which is the leading cause of severe visual impairment in older people. Opthea is developing a therapy aimed at inhibiting the excessive formation of blood vessels in the macula of the eye, which can impair vision. The drug called OPT-302 is used in combination therapies with existing treatments for wet AMD and has the potential to slow down the progression of the disease and improve vision. In addition to the therapy for wet AMD, Opthea is also researching therapy options for other eye diseases such as diabetic retinopathy, retinal vein occlusion, and corneal diseases. Opthea has filed numerous patents in this field and collaborates with various academic and clinical partners to advance the development of innovative therapies. Another important component of Opthea's business model is collaboration with established pharmaceutical companies. In 2020, Opthea entered into a licensing agreement with the pharmaceutical company Novartis, which includes exclusive distribution and marketing rights for the drug OPT-302 in Europe, Japan, and other countries outside of North America. This partnership allows Opthea to benefit from collaboration with an experienced and established partner while maximizing the potential of its innovative therapy. In summary, Opthea is a promising company in ophthalmology that specializes in the development of innovative therapies for various eye diseases. The company works closely with academic and clinical partners and leverages the advantages of partnerships with established pharmaceutical companies to maximize the potential of its therapies. With the therapy for wet AMD already in the pipeline, Opthea is expected to develop further therapy options in the future that will contribute to improving the lives of millions of patients worldwide. Opthea ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Opthea's Profit Margins
The profit margins of Opthea represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Opthea's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Opthea's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Opthea's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Opthea’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Opthea stock
How has the profit developed compared to last year?
The profit has increased by 54.53% compared to last year increased
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Opthea publish its earnings?
Opthea publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Opthea?
The profits of Opthea are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Opthea?
You can learn more about the earnings of Opthea by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Opthea pay?
Over the past 12 months, Opthea paid a dividend of 0.15 USD . This corresponds to a dividend yield of about 34.67 %. For the coming 12 months, Opthea is expected to pay a dividend of -0.05 USD.
What is the dividend yield of Opthea?
The current dividend yield of Opthea is 34.67 %.
When does Opthea pay dividends?
Opthea pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Opthea?
Opthea paid dividends every year for the past 4 years.
What is the dividend of Opthea?
For the upcoming 12 months, dividends amounting to -0.05 USD are expected. This corresponds to a dividend yield of -11.95 %.
In which sector is Opthea located?
Opthea is assigned to the 'Health' sector.
Wann musste ich die Aktien von Opthea kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Opthea from 2/24/2005 amounting to 0.15 USD, you needed to have the stock in your portfolio before the ex-date on 2/4/2005.
When did Opthea pay the last dividend?
The last dividend was paid out on 2/24/2005.
What was the dividend of Opthea in the year 2023?
In the year 2023, Opthea distributed 0 USD as dividends.
In which currency does Opthea pay out the dividend?
The dividends of Opthea are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Opthea
Our stock analysis for Opthea Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Opthea Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
